Entellus Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ENTL and buy or sell other stocks, ETFs, and their options commission-free!

About ENTL

Entellus Medical, Inc. is a medical technology company, which engages in the design, development, and commercialization of treatment of chronic and recurrent sinusitis in both adult and pediatric patients. The company was founded by Thomas V. 

CEO
James Andrew Pierce
CEOJames Andrew Pierce
Employees
Employees
Headquarters
St. Paul, Minnesota
HeadquartersSt. Paul, Minnesota
Founded
2006
Founded2006
Employees
Employees

ENTL Key Statistics

Market cap
610.75M
Market cap610.75M
Price-Earnings ratio
-18.60
Price-Earnings ratio-18.60
Dividend yield
Dividend yield
Average volume
88.99K
Average volume88.99K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$25.58
52 Week high$25.58
52 Week low
$11.47
52 Week low$11.47

Stock Snapshot

With a market cap of 610.75M, Entellus Medical(ENTL) trades at $24.00. The stock has a price-to-earnings ratio of -18.60.

On 2026-05-11, Entellus Medical(ENTL) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for Entellus Medical(ENTL) stock has reached 0, versus its average volume of 88.99K.

The stock's 52-week range extends from a low of $11.47 to a high of $25.58.

The stock's 52-week range extends from a low of $11.47 to a high of $25.58.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.